Avalere Health is proud to have assembled a diverse group of leaders and decision-makers in government, industry, and advocacy. These key players will engage you and each other in a dialogue on the current and future state of health reform are in the United States. Make your move with the insights of these speakers at the Avalere Health Health Reform & Commercial Marketplace conference.

Speaker Profiles /

Jan Berger | Melissa Boudreault | Chiquita Brooks-LaSure | Judy Feder | Liz Fowler | Paul Ginsburg | Jon Glaudemans | John Holahan | Bob Master | Robert Moffit | David Nexon | Jim Reddoch | Edwina Rogers | Henry Waxman | Gail Wilensky | Ellen Zane

		Jim Reddoch, Ph.D. Executive Vice President and Head of Research, Royalty Pharma Dr. Reddoch joined Royalty Pharma in July 2008 after a 12 years on Wall Street as a biotechnology analyst. Prior to joining Royalty Pharma, Dr. Reddoch was Managing Director and Head of Healthcare Equity Research at Friedman Billings Ramsey. He previously worked at Banc of America Securities and CIBC World Markets Corp. (now Oppenheimer & Co.). Dr. Reddoch holds a B.A. from Furman University and a Ph.D. in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham. He was a postdoctoral fellow at the Yale University School of Medicine.